{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:03:29Z","timestamp":1793466209945,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T00:00:00Z","timestamp":1619740800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T00:00:00Z","timestamp":1619740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Ubiquitin-conjugating enzyme E2W (<jats:italic>UBE2W<\/jats:italic>) is a protein-coding gene that has an important role in ubiquitination and may be vital in the repair of DNA damage. However, studies on the prognostic value of UBE2W and its correlation with tumor-infiltrating immune cells in multiple cancers have not been addressed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We investigated UBE2W expression in the Oncomine database, the Tumor Immune Estimation Resource (TIMER), TNMplot database. Then, the clinical prognostic value of UBE2W was analyzed via online public databases. Meanwhile, we explored the correlation between UBE2W and DNA repair associate genes expression and DNA methyltransferase expression by TIMER and Gene Expression Profiling Interactive Analysis (GEPIA). By using the same method, the correlation between UBE2W and tumor-infiltrating immune cells was explored. Genomic Profiles of UBE2W in breast cancer (BRCA) were accessed in cBioPortal (v3.5.0). Functional proteins associated network was analyzed by STRING database (v11.0).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>UBE2W was abnormally expressed and significantly correlated with mismatch repair (MMR) gene mutation levels, DNA methyltransferase, and BRCA1\/2 expression in breast cancer. High expression of UBE2W may promote the tumor immunosuppression and metastasis, induce endocrine therapy resistance and deteriorate outcomes of patients with breast cancer. These findings suggest that UBE2W could be a potential biomarker of prognosis and tumor-infiltrating immune cells. Besides, RBX1 may be a new E3 that was regulated by UBE2W.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Ubiquitin E2 UBE2W is a potential prognostic biomarker and is correlated with immune infiltration in BRCA.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-021-08234-4","type":"journal-article","created":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T04:02:47Z","timestamp":1619755367000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prognostic value of ubiquitin E2 UBE2W and its correlation with tumor-infiltrating immune cells in breast cancer"],"prefix":"10.1186","volume":"21","author":[{"given":"Yan","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Wei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Zhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Hong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,30]]},"reference":[{"issue":"6","key":"8234_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"8234_CR2","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S1470-2045(10)70005-X","volume":"11","author":"M Hartman","year":"2010","unstructured":"Hartman M, Loy EY, Ku CS, Chia KS. Molecular epidemiology and its current clinical use in cancer. Lancet Oncol. 2010;11(4):383\u201390. https:\/\/doi.org\/10.1016\/S1470-2045(10)70005-X.","journal-title":"Lancet Oncol"},{"issue":"10","key":"8234_CR3","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/nrc1994","volume":"6","author":"D Hoeller","year":"2006","unstructured":"Hoeller D, Hecker CM, Dikic I. Ubiquitin and ubiquitin-like proteins in cancer pathogenesis. Nat Rev Cancer. 2006;6(10):776\u201388. https:\/\/doi.org\/10.1038\/nrc1994.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"8234_CR4","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.tcb.2013.12.003","volume":"24","author":"G Kleiger","year":"2014","unstructured":"Kleiger G, Mayor T. Perilous journey: a tour of the ubiquitin\u2013proteasome system. Trends Cell Biol. 2014;24(6):352\u20139. https:\/\/doi.org\/10.1016\/j.tcb.2013.12.003.","journal-title":"Trends Cell Biol"},{"issue":"1","key":"8234_CR5","doi-asserted-by":"publisher","first-page":"25208","DOI":"10.1038\/srep25208","volume":"6","author":"F Ebstein","year":"2016","unstructured":"Ebstein F, Keller M, Paschen A, Walden P, Seeger M, Burger E, et al. Exposure to Melan-a\/MART-126-35 tumor epitope specific CD8(+)T cells reveals immune escape by affecting the ubiquitin-proteasome system (UPS). Sci Rep. 2016;6(1):25208. https:\/\/doi.org\/10.1038\/srep25208.","journal-title":"Sci Rep"},{"issue":"6","key":"8234_CR6","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.ceb.2009.09.005","volume":"21","author":"M Bader","year":"2009","unstructured":"Bader M, Steller H. Regulation of cell death by the ubiquitin\u2013proteasome system. Curr Opin Cell Biol. 2009;21(6):878\u201384. https:\/\/doi.org\/10.1016\/j.ceb.2009.09.005.","journal-title":"Curr Opin Cell Biol"},{"issue":"12","key":"8234_CR7","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.bbadis.2008.06.007","volume":"1782","author":"IA Voutsadakis","year":"2008","unstructured":"Voutsadakis IA. The ubiquitin-proteasome system in colorectal cancer. Biochim Biophys Acta (BBA) - Mol Basis Dis. 2008;1782(12):800\u20138. https:\/\/doi.org\/10.1016\/j.bbadis.2008.06.007.","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"issue":"12","key":"8234_CR8","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.bbadis.2008.08.003","volume":"1782","author":"SP Dawson","year":"2008","unstructured":"Dawson SP. Hepatocellular carcinoma and the ubiquitin\u2013proteasome system. Biochim Biophys Acta (BBA) - Mol Basis Dis. 2008;1782(12):775\u201384. https:\/\/doi.org\/10.1016\/j.bbadis.2008.08.003.","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"issue":"1","key":"8234_CR9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1042\/BJ20130244","volume":"453","author":"MH Tatham","year":"2013","unstructured":"Tatham MH, Plechanovova A, Jaffray EG, Salmen H, Hay RT. Ube2W conjugates ubiquitin to alpha-amino groups of protein N-termini. Biochem J. 2013;453(1):137\u201345. https:\/\/doi.org\/10.1042\/BJ20130244.","journal-title":"Biochem J"},{"issue":"6","key":"8234_CR10","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.molcel.2008.12.003","volume":"32","author":"A Alpi","year":"2008","unstructured":"Alpi A, Pace P, Babu M, Patel K. Mechanistic insight into site-restricted monoubiquitination of FANCD2 by Ube2t, FANCL, and FANCI. Mol Cell. 2008;32(6):767\u201377. https:\/\/doi.org\/10.1016\/j.molcel.2008.12.003.","journal-title":"Mol Cell"},{"issue":"2","key":"8234_CR11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s10059-011-0015-9","volume":"31","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Zhou X, Zhao L, Li C, Zhu H, Xu L, et al. UBE2W interacts with FANCL and regulates the monoubiquitination of fanconi anemia protein FANCD2. Molecules and Cells. 2010;31(2):113\u201322. https:\/\/doi.org\/10.1007\/s10059-011-0015-9.","journal-title":"Molecules and Cells"},{"key":"8234_CR12","doi-asserted-by":"crossref","unstructured":"Maure J-F, Moser SC, Jaffray EG, Alpi AF, Hay RT. Loss of ubiquitin E2 Ube2w rescues hypersensitivity of Rnf4 mutant cells to DNA damage. Sci Rep. 2016;6(1):26178.","DOI":"10.1038\/srep26178"},{"issue":"10","key":"8234_CR13","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nsmb1295","volume":"14","author":"DE Christensen","year":"2007","unstructured":"Christensen DE, Brzovic PS, Klevit RE. E2\u2013BRCA1 RING interactions dictate synthesis of mono- or specific polyubiquitin chain linkages. Nat Struct Mol Biol. 2007;14(10):941\u20138. https:\/\/doi.org\/10.1038\/nsmb1295.","journal-title":"Nat Struct Mol Biol"},{"issue":"5","key":"8234_CR14","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.molmed.2019.02.002","volume":"25","author":"Y Fujita","year":"2019","unstructured":"Fujita Y, Tinoco R, Li Y, Senft D, Ronai ZA. Ubiquitin ligases in Cancer immunotherapy - balancing antitumor and autoimmunity. Trends Mol Med. 2019;25(5):428\u201343. https:\/\/doi.org\/10.1016\/j.molmed.2019.02.002.","journal-title":"Trends Mol Med"},{"issue":"1","key":"8234_CR15","doi-asserted-by":"publisher","first-page":"1746148","DOI":"10.1080\/2162402X.2020.1746148","volume":"9","author":"M Song","year":"2020","unstructured":"Song M, Wang C, Wang H, Zhang T, Li J, Benezra R, et al. Targeting ubiquitin protein ligase E3 component N-recognin 5 in cancer cells induces a CD8+ T cell mediated immune response. Oncoimmunology. 2020;9(1):1746148. https:\/\/doi.org\/10.1080\/2162402X.2020.1746148.","journal-title":"Oncoimmunology"},{"issue":"11","key":"8234_CR16","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/j.drudis.2020.09.015","volume":"25","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Chen R, Luo X, Zhang WD, Qin JJ. The E2 ubiquitin-conjugating enzyme UbcH5c: an emerging target in cancer and immune disorders. Drug Discov Today. 2020;25(11):1988\u201397. https:\/\/doi.org\/10.1016\/j.drudis.2020.09.015.","journal-title":"Drug Discov Today"},{"issue":"2","key":"8234_CR17","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1593\/neo.07112","volume":"9","author":"DR Rhodes","year":"2007","unstructured":"Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Varambally R, Yu J, Briggs BB, et al. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia. 2007;9(2):166\u201380. https:\/\/doi.org\/10.1593\/neo.07112.","journal-title":"Neoplasia"},{"issue":"W1","key":"8234_CR18","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509\u201314. https:\/\/doi.org\/10.1093\/nar\/gkaa407.","journal-title":"Nucleic Acids Res"},{"issue":"21","key":"8234_CR19","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, et al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 2017;77(21):e108\u201310. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0307.","journal-title":"Cancer Res"},{"issue":"1","key":"8234_CR20","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13059-016-1028-7","volume":"17","author":"B Li","year":"2016","unstructured":"Li B, Severson E, Pignon JC, Zhao H, Li T, Novak J, et al. Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. Genome Biol. 2016;17(1):174. https:\/\/doi.org\/10.1186\/s13059-016-1028-7.","journal-title":"Genome Biol"},{"key":"8234_CR21","doi-asserted-by":"crossref","unstructured":"Bartha \u00c1, Gy\u0151rffy B. TNMplot.com: a web tool for the comparison of gene expression in normal, tumor and metastatic tissues. Int J Mol Sci. 2021;22(5):2622.","DOI":"10.3390\/ijms22052622"},{"issue":"6220","key":"8234_CR22","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n M, Fagerberg L, Hallstr\u00f6m B, Lindskog C, Oksvold P, Mardinoglu A, et al. Proteomics. Tissue-based map of the human proteome. Science (New York, NY). 2015;347(6220):1260419.","journal-title":"Science (New York, NY)"},{"issue":"3","key":"8234_CR23","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10549-009-0674-9","volume":"123","author":"B Gyorffy","year":"2010","unstructured":"Gyorffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q, et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat. 2010;123(3):725\u201331. https:\/\/doi.org\/10.1007\/s10549-009-0674-9.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"8234_CR24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1755-8794-2-18","volume":"2","author":"H Mizuno","year":"2009","unstructured":"Mizuno H, Kitada K, Nakai K, Sarai A. PrognoScan: a new database for meta-analysis of the prognostic value of genes. BMC Med Genet. 2009;2(1):18. https:\/\/doi.org\/10.1186\/1755-8794-2-18.","journal-title":"BMC Med Genet"},{"issue":"11","key":"8234_CR25","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1002\/ijc.32369","volume":"145","author":"J Fekete","year":"2019","unstructured":"Fekete J, Gyorffy B. ROCplot.org: validating predictive biomarkers of chemotherapy\/hormonal therapy\/anti-HER2 therapy using transcriptomic data of 3,104 breast cancer patients. Int J Cancer. 2019;145(11):3140\u201351. https:\/\/doi.org\/10.1002\/ijc.32369.","journal-title":"Int J Cancer"},{"issue":"D1","key":"8234_CR26","doi-asserted-by":"publisher","first-page":"D721","DOI":"10.1093\/nar\/gky900","volume":"47","author":"X Zhang","year":"2019","unstructured":"Zhang X, Lan Y, Xu J, Quan F, Zhao E, Deng C, et al. CellMarker: a manually curated resource of cell markers in human and mouse. Nucleic Acids Res. 2019;47(D1):D721\u20138. https:\/\/doi.org\/10.1093\/nar\/gky900.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"8234_CR27","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98\u2013W102. https:\/\/doi.org\/10.1093\/nar\/gkx247.","journal-title":"Nucleic Acids Res"},{"issue":"269","key":"8234_CR28","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):pl1. https:\/\/doi.org\/10.1126\/scisignal.2004088.","journal-title":"Sci Signal"},{"issue":"5","key":"8234_CR29","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio Cancer genomics portal: an open platform for exploring multidimensional Cancer genomics data: figure 1. Cancer Discovery. 2012;2(5):401\u20134. https:\/\/doi.org\/10.1158\/2159-8290.CD-12-0095.","journal-title":"Cancer Discovery"},{"key":"8234_CR30","doi-asserted-by":"crossref","unstructured":"Szklarczyk D, Gable AL, Nastou KC, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res. 2021;49:D605\u2013D612.","DOI":"10.1093\/nar\/gkaa1074"},{"issue":"1","key":"8234_CR31","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1146\/annurev.micro.57.030502.090847","volume":"57","author":"MJ Schofield","year":"2003","unstructured":"Schofield MJ, Hsieh P. DNA mismatch repair: molecular mechanisms and biological function. Annu Rev Microbiol. 2003;57(1):579\u2013608. https:\/\/doi.org\/10.1146\/annurev.micro.57.030502.090847.","journal-title":"Annu Rev Microbiol"},{"issue":"11","key":"8234_CR32","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/j.1349-7006.2004.tb02195.x","volume":"95","author":"K Yoshida","year":"2004","unstructured":"Yoshida K, Miki Y. Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage. Cancer Sci. 2004;95(11):866\u201371. https:\/\/doi.org\/10.1111\/j.1349-7006.2004.tb02195.x.","journal-title":"Cancer Sci"},{"key":"8234_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bcp.2016.12.004","volume":"129","author":"D Pechalrieu","year":"2017","unstructured":"Pechalrieu D, Etievant C, Arimondo PB. DNA methyltransferase inhibitors in cancer: from pharmacology to translational studies. Biochem Pharmacol. 2017;129:1\u201313. https:\/\/doi.org\/10.1016\/j.bcp.2016.12.004.","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"8234_CR34","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1158\/2159-8290.CD-16-1179","volume":"7","author":"S Haricharan","year":"2017","unstructured":"Haricharan S, Punturi N, Singh P, Holloway KR, Anurag M, Schmelz J, et al. Loss of MutL disrupts CHK2-dependent cell-cycle control through CDK4\/6 to promote intrinsic endocrine therapy resistance in primary breast Cancer. Cancer Discov. 2017;7(10):1168\u201383. https:\/\/doi.org\/10.1158\/2159-8290.CD-16-1179.","journal-title":"Cancer Discov"},{"key":"8234_CR35","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.gene.2018.10.060","volume":"685","author":"R Jahangiri","year":"2019","unstructured":"Jahangiri R, Jamialahmadi K, Gharib M, Emami Razavi A, Mosaffa F. Expression and clinicopathological significance of DNA methyltransferase 1, 3A and 3B in tamoxifen-treated breast cancer patients. Gene. 2019;685:24\u201331. https:\/\/doi.org\/10.1016\/j.gene.2018.10.060.","journal-title":"Gene"},{"key":"8234_CR36","doi-asserted-by":"crossref","unstructured":"Ter Brugge P, Kristel P, van der Burg E, Boon U, de Maaker M, Lips E, et al. Mechanisms of Therapy Resistance in Patient-Derived Xenograft Models of BRCA1-Deficient Breast Cancer. J Natl Cancer Inst. 2016;108(11).","DOI":"10.1093\/jnci\/djw148"},{"issue":"4","key":"8234_CR37","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1158\/0008-5472.CAN-09-3292","volume":"70","author":"CM Joffroy","year":"2010","unstructured":"Joffroy CM, Buck MB, Stope MB, Popp SL, Pfizenmaier K, Knabbe C. Antiestrogens induce transforming growth factor beta-mediated immunosuppression in breast cancer. Cancer Res. 2010;70(4):1314\u201322. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-3292.","journal-title":"Cancer Res"},{"issue":"1","key":"8234_CR38","doi-asserted-by":"publisher","first-page":"11479","DOI":"10.1038\/ncomms11479","volume":"7","author":"B Pereira","year":"2016","unstructured":"Pereira B, Chin SF, Rueda OM, Vollan HK, Provenzano E, Bardwell HA, et al. The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes. Nat Commun. 2016;7(1):11479. https:\/\/doi.org\/10.1038\/ncomms11479.","journal-title":"Nat Commun"},{"issue":"7403","key":"8234_CR39","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10983","volume":"486","author":"C Curtis","year":"2012","unstructured":"Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012;486(7403):346\u201352. https:\/\/doi.org\/10.1038\/nature10983.","journal-title":"Nature"},{"issue":"7748","key":"8234_CR40","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41586-019-1007-8","volume":"567","author":"OM Rueda","year":"2019","unstructured":"Rueda OM, Sammut SJ, Seoane JA, Chin SF, Caswell-Jin JL, Callari M, et al. Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups. Nature. 2019;567(7748):399\u2013404. https:\/\/doi.org\/10.1038\/s41586-019-1007-8.","journal-title":"Nature"},{"issue":"1","key":"8234_CR41","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.2741\/1899","volume":"11","author":"G Yin","year":"2006","unstructured":"Yin G, Ji C, Wu T, Shen Z, Xu X, Xie Y, et al. Cloning, characterization and subcellular localization of a gene encoding a human ubiquitin-conjugating enzyme (E2) homologous to the Arabidopsis thaliana UBC-16 gene product. Front Biosci. 2006;11(1):1500\u20137. https:\/\/doi.org\/10.2741\/1899.","journal-title":"Front Biosci"},{"issue":"4","key":"8234_CR42","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.molcel.2011.05.036","volume":"43","author":"KM Scaglione","year":"2011","unstructured":"Scaglione KM, Zavodszky E, Todi SV, Patury S, Xu P, Rodriguez-Lebron E, et al. Ube2w and ataxin-3 coordinately regulate the ubiquitin ligase CHIP. Mol Cell. 2011;43(4):599\u2013612. https:\/\/doi.org\/10.1016\/j.molcel.2011.05.036.","journal-title":"Mol Cell"},{"issue":"Pt A","key":"8234_CR43","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.nbd.2017.10.002","volume":"109","author":"B Wang","year":"2018","unstructured":"Wang B, Zeng L, Merillat SA, Fischer S, Ochaba J, Thompson LM, et al. The ubiquitin conjugating enzyme Ube2W regulates solubility of the Huntington's disease protein, huntingtin. Neurobiol Dis. 2018;109(Pt A):127\u201336.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"8234_CR44","doi-asserted-by":"publisher","DOI":"10.1111\/and.13474","volume":"52","author":"B Lei","year":"2020","unstructured":"Lei B, Xie L, Zhang S, Lv D, Shu F, Deng Y. UBE2W down-regulation promotes cell apoptosis and correlates with hypospermatogenesis. Andrologia. 2020;52(1):e13474. https:\/\/doi.org\/10.1111\/and.13474.","journal-title":"Andrologia"},{"issue":"3","key":"8234_CR45","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1074\/mcp.M114.045211","volume":"14","author":"J Xu","year":"2015","unstructured":"Xu J, Li L, Yu G, Ying W, Gao Q, Zhang W, et al. The neddylation-cullin 2-RBX1 E3 ligase axis targets tumor suppressor RhoB for degradation in liver cancer. Mol Cell Proteomics. 2015;14(3):499\u2013509. https:\/\/doi.org\/10.1074\/mcp.M114.045211.","journal-title":"Mol Cell Proteomics"},{"issue":"3","key":"8234_CR46","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.suronc.2016.05.006","volume":"25","author":"R Xing","year":"2016","unstructured":"Xing R, Chen KB, Xuan Y, Feng C, Xue M, Zeng YC. RBX1 expression is an unfavorable prognostic factor in patients with non-small cell lung cancer. Surg Oncol. 2016;25(3):147\u201351. https:\/\/doi.org\/10.1016\/j.suronc.2016.05.006.","journal-title":"Surg Oncol"},{"issue":"1","key":"8234_CR47","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s10549-014-2991-x","volume":"146","author":"S Haricharan","year":"2014","unstructured":"Haricharan S, Bainbridge MN, Scheet P, Brown PH. Somatic mutation load of estrogen receptor-positive breast tumors predicts overall survival: an analysis of genome sequence data. Breast Cancer Res Treat. 2014;146(1):211\u201320. https:\/\/doi.org\/10.1007\/s10549-014-2991-x.","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"8234_CR48","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/nrclinonc.2010.172","volume":"7","author":"FL Rehman","year":"2010","unstructured":"Rehman FL, Lord CJ, Ashworth A. Synthetic lethal approaches to breast cancer therapy. Nat Rev Clin Oncol. 2010;7(12):718\u201324. https:\/\/doi.org\/10.1038\/nrclinonc.2010.172.","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"8234_CR49","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.clbc.2017.12.010","volume":"18","author":"EL Gornstein","year":"2018","unstructured":"Gornstein EL, Sandefur S, Chung JH, Gay LM, Holmes O, Erlich RL, et al. BRCA2 reversion mutation associated with acquired resistance to Olaparib in estrogen receptor-positive breast Cancer detected by genomic profiling of tissue and liquid biopsy. Clin Breast Cancer. 2018;18(2):184\u20138. https:\/\/doi.org\/10.1016\/j.clbc.2017.12.010.","journal-title":"Clin Breast Cancer"},{"issue":"5","key":"8234_CR50","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nrm1907","volume":"7","author":"J Jiricny","year":"2006","unstructured":"Jiricny J. The multifaceted mismatch-repair system. Nat Rev Mol Cell Biol. 2006;7(5):335\u201346. https:\/\/doi.org\/10.1038\/nrm1907.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"8234_CR51","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.drudis.2016.05.012","volume":"21","author":"T De Marchi","year":"2016","unstructured":"De Marchi T, Foekens JA, Umar A, Martens JW. Endocrine therapy resistance in estrogen receptor (ER)-positive breast cancer. Drug Discov Today. 2016;21(7):1181\u20138. https:\/\/doi.org\/10.1016\/j.drudis.2016.05.012.","journal-title":"Drug Discov Today"},{"key":"8234_CR52","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ctrv.2016.08.008","volume":"50","author":"K Tryfonidis","year":"2016","unstructured":"Tryfonidis K, Zardavas D, Katzenellenbogen BS, Piccart M. Endocrine treatment in breast cancer: cure, resistance and beyond. Cancer Treat Rev. 2016;50:68\u201381. https:\/\/doi.org\/10.1016\/j.ctrv.2016.08.008.","journal-title":"Cancer Treat Rev"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08234-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-08234-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08234-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T04:03:03Z","timestamp":1619755383000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-08234-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,30]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["8234"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-08234-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,30]]},"assertion":[{"value":"5 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"479"}}